Lifevantage EBITDA Margin 2010-2024 | LFVN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Lifevantage (LFVN) over the last 10 years. The current EBITDA margin for Lifevantage as of December 31, 2024 is .
| Lifevantage EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-12-31 |
$0.21B |
$0.01B |
6.60% |
| 2024-09-30 |
$0.20B |
$0.01B |
5.10% |
| 2024-06-30 |
$0.20B |
$0.01B |
4.50% |
| 2024-03-31 |
$0.21B |
$0.01B |
4.39% |
| 2023-12-31 |
$0.21B |
$0.01B |
3.79% |
| 2023-09-30 |
$0.21B |
$0.01B |
3.76% |
| 2023-06-30 |
$0.21B |
$0.01B |
3.74% |
| 2023-03-31 |
$0.21B |
$0.01B |
2.37% |
| 2022-12-31 |
$0.21B |
$0.01B |
2.90% |
| 2022-09-30 |
$0.21B |
$0.01B |
3.41% |
| 2022-06-30 |
$0.21B |
$0.01B |
5.34% |
| 2022-03-31 |
$0.21B |
$0.02B |
8.57% |
| 2021-12-31 |
$0.21B |
$0.02B |
8.49% |
| 2021-09-30 |
$0.22B |
$0.02B |
10.96% |
| 2021-06-30 |
$0.22B |
$0.02B |
10.86% |
| 2021-03-31 |
$0.23B |
$0.02B |
10.67% |
| 2020-12-31 |
$0.23B |
$0.03B |
10.92% |
| 2020-09-30 |
$0.23B |
$0.02B |
9.96% |
| 2020-06-30 |
$0.23B |
$0.02B |
9.05% |
| 2020-03-31 |
$0.23B |
$0.02B |
8.30% |
| 2019-12-31 |
$0.23B |
$0.02B |
7.86% |
| 2019-09-30 |
$0.23B |
$0.01B |
6.19% |
| 2019-06-30 |
$0.23B |
$0.01B |
5.31% |
| 2019-03-31 |
$0.22B |
$0.01B |
4.91% |
| 2018-12-31 |
$0.22B |
$0.01B |
5.02% |
| 2018-09-30 |
$0.21B |
$0.01B |
6.19% |
| 2018-06-30 |
$0.20B |
$0.01B |
6.40% |
| 2018-03-31 |
$0.20B |
$0.01B |
5.00% |
| 2017-12-31 |
$0.19B |
$0.01B |
4.12% |
| 2017-09-30 |
$0.19B |
$0.01B |
3.09% |
| 2017-06-30 |
$0.20B |
$0.01B |
3.00% |
| 2017-03-31 |
$0.20B |
$0.01B |
4.46% |
| 2016-12-31 |
$0.21B |
$0.01B |
5.63% |
| 2016-09-30 |
$0.22B |
$0.02B |
6.94% |
| 2016-06-30 |
$0.21B |
$0.02B |
7.77% |
| 2016-03-31 |
$0.20B |
$0.01B |
6.57% |
| 2015-12-31 |
$0.19B |
$0.01B |
5.88% |
| 2015-09-30 |
$0.18B |
$0.01B |
6.01% |
| 2015-06-30 |
$0.19B |
$0.02B |
8.42% |
| 2015-03-31 |
$0.20B |
$0.02B |
9.45% |
| 2014-12-31 |
$0.21B |
$0.02B |
10.43% |
| 2014-09-30 |
$0.22B |
$0.02B |
11.16% |
| 2014-06-30 |
$0.21B |
$0.02B |
10.28% |
| 2014-03-31 |
$0.21B |
$0.02B |
8.57% |
| 2013-12-31 |
$0.21B |
$0.02B |
8.29% |
| 2013-09-30 |
$0.21B |
$0.01B |
5.83% |
| 2013-06-30 |
$0.21B |
$0.01B |
6.25% |
| 2013-03-31 |
$0.20B |
$0.02B |
9.95% |
| 2012-12-31 |
$0.19B |
$0.02B |
12.30% |
| 2012-09-30 |
$0.16B |
$0.03B |
16.35% |
| 2012-06-30 |
$0.13B |
$0.02B |
18.25% |
| 2012-03-31 |
$0.10B |
$0.02B |
17.71% |
| 2011-12-31 |
$0.07B |
$0.01B |
12.86% |
| 2011-09-30 |
$0.05B |
$0.01B |
13.46% |
| 2011-06-30 |
$0.04B |
$0.00B |
7.89% |
| 2011-03-31 |
$0.03B |
0 |
0.00% |
| 2010-12-31 |
$0.02B |
0 |
0.00% |
| 2010-09-30 |
$0.02B |
$-0.00B |
-26.67% |
| 2010-06-30 |
$0.01B |
$-0.01B |
-63.64% |
| 2010-03-31 |
$0.01B |
$-0.01B |
-122.22% |
| 2009-12-31 |
$0.01B |
$-0.01B |
-171.43% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.183B |
$0.200B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
